Breaking News
Upgrade 0
🚪 November's AI-picked stock list about to go live. Opportunity is knocking...
Get the list
Close

Manulife Srp Balanced Portfolio (0P0000XQG4)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1.707 -0.008    -0.45%
30/10 - Closed. Currency in USD
Type:  Fund
Market:  Singapore
Issuer:  Manulife (Singapore) Pte Ltd
Asset Class:  Equity
  • Morningstar Rating:
  • Total Assets: 5.01M
Manulife SRP Balanced Portfolio 1.707 -0.008 -0.45%

0P0000XQG4 Holdings

 
Comprehensive information about top holdings and Key Holding Information for the Manulife SRP Balanced Portfolio (0P0000XQG4) fund. Our Manulife SRP Balanced Portfolio portfolio information includes stock holdings, annual turnover, top 10 holdings, sector and asset allocation.

Asset Allocation

Create Alert
Add to Watchlist
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Name  Net %  Long %  Short %
Cash 1.980 2.030 0.050
Shares 39.710 39.710 0.000
Bonds 49.830 49.830 0.000
Convertible 0.670 0.670 0.000
Preferred 7.690 7.690 0.000
Other 0.120 0.120 0.000

 Style Box

Value & Growth Measures

Ratios Value Category Average
P/E Ratio 20.516 18.347
Price to Book 2.904 2.907
Price to Sales 2.547 2.107
Price to Cash Flow 13.272 11.706
Dividend Yield 1.934 2.411
5 Years Earnings Growth 8.756 9.665

Sector Allocation

Name  Net % Category Average
Technology 25.870 22.098
Consumer Cyclical 14.020 9.696
Real Estate 13.370 5.588
Financial Services 11.540 18.098
Communication Services 10.970 7.870
Healthcare 10.370 9.560
Industrials 6.220 11.417
Energy 3.440 4.017
Consumer Defensive 3.370 6.574
Basic Materials 0.510 3.521
Utilities 0.330 3.369

Region Allocation

  • North America
  • Latin America
  • Europe Developed
  • Asia
  • Australasia
  • Africa & Middle East
  • Emerging Markets
  • Developed Markets

Top Holdings

Number of long holdings: 7

Number of short holdings: 0

Name ISIN Weight % Last Change %
  Manulife Global Fund - U.S. Bond Fund AA LU0278409817 45.97 1.034 -0.02%
Manulife GF US Eq AA Shrs LU0314104364 24.42 - -
Manulife GF US Special Opps AA LU0278410153 13.28 - -
Manulife GF Dynamic Leaders AA Acc LU2746668461 7.12 - -
  Manulife Global Fund Global Property Fund AA LU0278409221 5.15 1.024 -0.11%
Manulife GF Japan Eq AA Shrs LU0314107540 3.03 - -
  Manulife Global Fund Asian Equity Fund AA LU0314105171 1.03 1.727 -0.86%

Top Equity Funds by Manulife (Singapore) Pte Ltd

  Name Rating Total Assets YTD% 3Y% 10Y%
  Manulife SRP Aggressive Portfolio 26.42M 6.21 14.38 6.66
  Manulife SRP Growth Portfolio 14.53M 5.71 11.41 5.11
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

0P0000XQG4 Comments

Write your thoughts about Manulife Srp Balanced Portfolio
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email